NHSL1 and hepatocellular carcinoma: For patients with virus-positive HCC, higher NHSL1 mRNA expressions were associated with a significantly better prognosis, with a hazard ratio (HR) of 0.26 (range, 0.1–0.7; p = 0.0043) (Figure 4D, left).